RxDoctor Payments Data

Adam Cohen, MD

Medical Oncology · Fairfax, VANPI 1528281375

Payments from drug & device makers

What this record shows

That places this record below the midpoint for medical oncology clinicians in VA, where the typical reported total is $926.

$84in general payments, 2019–2025

Across 2 payments — averaging $41.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$43
  • Janssen Global Services, LLC$41
$2,210,193in research payments, 2019–2025

Across 252 payments — averaging $8770.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$923K
  • AstraZeneca$617K
  • AbbVie$201K
  • Pfizer$180K
  • Daiichi Sankyo Inc.$117K
  • E.r. Squibb & Sons, L.L.C.$60K
  • plus $111K from 4 others

What the payments were for

  • Food & beverage$4148%
  • Education$4352%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca1$43
Janssen Global Services, LLC1$41

How this compares

$84 in reported general payments places this provider in the 15th percentile of 95 medical oncology providers in Virginia.

See all medical oncology providers in Virginia

Medicare billing

Part B allowed, 2024
$53,696
Medicare patients
129
Services billed
444

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban21$18,518
Levetiracetam69$2,948
Dexamethasone105$1,663
Lacosamide15$1,065
Gabapentin14$488
Ondansetron Hcl30$315
Divalproex Sodium13$168
Trazodone Hcl13$31
Lorazepam14$18

Paid to pharmacies, not to this prescriber.

Other medical oncology in Fairfax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →